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 Soon after the discovery of x-rays by Roentgen, 
radioactivity by Becquerel, and radium by the Curies, it 
was concluded that x-rays could not only be used for 
diagnostic purposes but also for therapy [1,2]. In the 
early years of radiation therapy, physicians had little 
understanding or knowledge of the physical nature and 
biological effects of radiation, the delivered doses were 
not certain, the equipment was not just primitive and 
temperamental but limited in energy output and as such 
was associated with high failure rates, numerous tumour 
recurrences and complications. Radiotherapy today has 
come a long way and has become an essential tool in the 
treatment of cancer and other diseases along with 
surgery, chemotherapy, image guided interventions, and 
targeted radionuclide therapy [3]. In addition, newer 
biological therapies (immunotherapy, biotherapy, or 
biological response modifier therapy) are fast becoming 
part of the widened armamentarium [4]. This special 
focused issue of biij will cover some of these topics.  
From a common origin based on x-rays, the 
diagnostic and therapeutic aspects diverged over the last 
110 years or so. The early practitioners of radiation 
therapy and diagnostic radiology began as members of 
other specialties. Dermatologists and surgeons comprised 
significant numbers of these early radiation pioneers with 
even a greater percentage coming from the “field” of 
electrotherapy. If one reviews some of the early 
monographs, the titles illustrate the close connection 
between the two fields of radiation therapy and 
diagnostic radiology [5,6]. But we seem to have come 
full circle with the increasing convergence between the 
therapy and diagnostic aspects with increasingly role of 
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imaging for therapy planning as well as real-time 
monitoring of therapy, e.g. IMRT [7] and tomotherapy 
[8]. Convergence is also occurring in the minimally 
invasive image guided therapy and interventional 
radiology where there is use of targeted radiotherapy 
using yttrium embolospheres [9], brachytherapy for the 
treatment of restenoses following angioplasty [10], 
radiation synovectomies [11], radiofrequency ablation 
[12], high intensity focused ultrasound or the use of 
immunotherapy for the management of lymphoma [3]. 
Very often these different modalities have to be used in 
combination to deliver the best effects [13]. The ultimate 
goal of all the developments and improvements is the 
effective destruction of only the cancer tissue with little 
radiation damage to adjacent healthy tissues and to make 
the treatment easier and shorter for both the patients [14] 
and the physicians and other healthcare professionals to 
perform.  
The era of molecular medicine with its new insights 
is having a major effect on the diagnosis, treatment, and 
prevention of disease and the disciplines of radiology, 
nuclear medicine, and image-guided therapy and 
radiation oncology are not exempt. On the contrary, 
exciting challenges and opportunities in the 
technologically oriented disciplines of radiology and 
radiation therapy are leading in new directions other than 
those mentioned above. The National Cancer Institute 
(NCI) of USA had outlined a concept that included the 
three Ds: discovery, development, and delivery where the 
fields of diagnostic imaging, nuclear medicine, image-
guided therapy and radiation therapy can be important 
contributors to science and health care within this new 
paradigm [15]. Discovery can be equated with molecular 
signatures which are the fundamental underpinning, 
while imaging and therapeutics each comprise the 
combined components of development plus delivery. At B.J.J. Abdullah et al. Biomed Imaging Interv J 2006; 2(1):e1  2 
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the 2002 RSNA Annual Oration in Radiation Oncology, 
C. Norman Coleman, MD, who subtitled his presentation 
as, “Now That Therapy and Diagnosis Have Separated, 
It’s Time to Get Together Again!” reflected his opinion 
that there is a need for collaboration in research and 
training among the radiology disciplines with radiation 
oncologists needing to understand imaging as well as the 
underlying biologic mechanisms that produce the image 
findings; the diagnostic radiologists and nuclear medicine 
physicians in turn need to understand how images are 
used by radiation oncologists [16]. He went on to add 
that all trainees need a solid background in basic biology 
and the new molecular biology techniques. More 
importantly he stated that the trainees should be 
sufficiently intrigued and excited by the emerging 
science to maintain an active interest in clinical and 
laboratory investigations.  
It has been said that when we feel uncomfortable 
about changes occurring in our environment, we should 
resist the temptation to withdraw into our comfort zones 
but rather explore these new possibilities that may herald 
the dawn of a better era for patients and community. 
With the increased blurred borders between the various 
“traditionally” defined disciplines this discomfort is 
easily appreciated but as has been very succinctly put 
[17]:  
 
“Change has a considerable psychological impact on the 
human mind. To the fearful it is threatening because it 
means that things may get worse. To the hopeful it is 
encouraging because things may get better. To the confident 
it is inspiring because the challenge exists to make things 
better.”  
 
Obviously, then, one’s character and frame of mind 
determine how readily he brings about change and how he 
reacts to change that is imposed on him.  
– King Whitney Jr.  
 
If we take the cue, then the technologically oriented 
radiological fields – diagnostic imaging, interventional 
radiology and radiation oncology – have the opportunity 
to be leaders in these new paradigms (molecular imaging, 
signatures, and therapy) and we should together aim our 
efforts in terms of helping with the newest extraordinary 
opportunity for cancer survivorship [16]. 
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